[Clinical aspects of hepatitis C virus infection in child-bearing aged women.]
June 3, 2008 NursingA d v e r t i s e m e n t s
| Related Articles |
[Clinical aspects of hepatitis C virus infection in child-bearing aged women.]
Orv Hetil. 2008 Jun 1;149(22):1017-21
Authors: Lombay B, Gasztonyi B, Szalay F
It is difficult to define the optimal timing of antiviral treatment in women infected with viral hepatitis C, who have child-bearing potential. Antiviral treatment is strictly contraindicated during pregnancy and the breast-feeding period. Data are conflicting about the question of treatment with modern drugs (peginterferon and ribavirin) before or after pregnancy. The risk of vertical transmission from mother to child is estimated about 5%. The mother’s viraemia seems to be the main transmission factor. There is a worse prognosis in nulliparous and postmenopausal women in the natural history of viral hepatitis C. Poor outcome in gestational age, maturity and Apgar score were not associated with hepatitis C virus infection. Combined treatment has frequent gynecological and other side effects. The timing of antiviral therapy in women in child-bearing period is recommended individually.
PMID: 18508735 [PubMed - in process]
Related Journals:
- Inhibition of HTLV-1 cell-to-cell transmission in vitro by carbohydrate-binding agents.
- Extremely High Prevalence and Genetic Diversity of Hepatitis C Virus Infection among HIV-Infected Injection Drug Users in Taiwan.
- Preconception Care & PREGNANCY PLANNING: Voices of African American Women.
- [Influenza type A (H5N1) virus infection]
- Limitations of current prophylaxis against influenza virus infection.
Comments
Leave a Reply